Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy.

[1]  A. Davis,et al.  Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. , 2002, The Journal of clinical investigation.

[2]  M. Silverberg,et al.  Pathways for bradykinin formation and inflammatory disease. , 2002, The Journal of allergy and clinical immunology.

[3]  W. Tremaine,et al.  Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.

[4]  M. Kurabayashi,et al.  Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women , 2001, Menopause.

[5]  A. Toutain,et al.  Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. , 2001, The Journal of allergy and clinical immunology.

[6]  J. Weiler,et al.  A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. , 2001, Clinical immunology.

[7]  K. Binkley,et al.  Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.

[8]  D. Mccluskey,et al.  Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman. , 2000, The American journal of the medical sciences.

[9]  K. Bork,et al.  Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.

[10]  B. Zuraw,et al.  Detection of C1 inhibitor mutations in patients with hereditary angioedema. , 2000, The Journal of allergy and clinical immunology.

[11]  M. Cicardi,et al.  Plasma bradykinin in angio-oedema , 1998, The Lancet.

[12]  A. Fletcher,et al.  Coexistence of hereditary angioedema and Turner's syndrome. , 1998, Postgraduate medical journal.

[13]  H. Schunkert,et al.  Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. , 1997, Circulation.

[14]  H. Bürgi,et al.  Type I hereditary angio‐oedema. Variability of clinical presentation and course within two large kindreds , 1997, Journal of internal medicine.

[15]  S. Misiti,et al.  Estrogen induction and contact phase activation of human factor XII , 1996, Steroids.

[16]  J. Gran,et al.  Hereditary angio‐oedema: new clinical observations and autoimmune screening, complement and kallikrein‐kinin analyses , 1996, Journal of internal medicine.

[17]  I. Fogelman,et al.  Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women , 1995, The Lancet.

[18]  T. Mollnes,et al.  Effect of time, temperature and additives on a functional assay of C1 inhibitor. , 1994, Journal of immunological methods.

[19]  N. Hoem,et al.  Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII. , 1994, Thrombosis research.

[20]  W. Cunliffe,et al.  HORMONALLY EXACERBATED HEREDITARY ANGIOEDEMA , 1992, The Australasian journal of dermatology.

[21]  M. Greaves,et al.  Angioedema: manifestations and management. , 1991, Journal of the American Academy of Dermatology.

[22]  J. Jespersen,et al.  Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma. , 1990, Clinical chemistry.

[23]  M. Rybojad,et al.  Hereditary angioedema and oral contraception. , 1990, Dermatologica.

[24]  K. Bork,et al.  [Contraception and pregnancy in hereditary angioedema]. , 2008, Deutsche medizinische Wochenschrift.

[25]  G. Lagrue,et al.  [Hereditary angioneurotic edema: norgestrienone is not effective in every case]. , 1987, Presse medicale.

[26]  C. Jamin,et al.  Oedéme angioneurotique héréditaire: la norgestriénone n'est pas active dans tous les cas. , 1987 .

[27]  W. Cunliffe,et al.  Recurrent angioedema: familial and oestrogen‐induced , 1986, The British journal of dermatology.

[28]  Wautier Jl,et al.  [Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema]. , 1986 .

[29]  O. Ratnoff,et al.  Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. , 1980, The Journal of laboratory and clinical medicine.

[30]  M. Frank.  Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema. , 1979, Arthritis and rheumatism.

[31]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[32]  J. S. O'Toole.  Hereditary angio-edema. , 1970, Northwest medicine.

[33]  R. L. Wolf.  Angioneurotic edema from an oral contraceptive. , 1967, JAMA.

[34]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.

[35]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[36]  R. G. Fraser,et al.  Hereditary cardiovascular dysplasia. A form of familial cardiomyopathy. , 1961, The American journal of medicine.

[37]  W. Osler.  HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .